Educational Activities

Home > The Conference

Overview

Vivian and Seymour Milstein Family Heart Center

This program is not CME accredited.

Now in its 11th year of clinical trials, the application of stem cells in the treatment of cardiovascular diseases has seen many notable successes, as well as identified challenges that await the next round of clinical studies.

The program will be dedicated to the evolving field of cell-based therapies for the repair and regeneration of cardiac and vascular disease, as well as related diseases such as diabetes and stroke. This year’s conference will focus on preclinical and clinical studies on the path to commercialization, highlighting the status of molecular, cell, and tissue products in addition to delivery systems.

Leaders from the international community will convene to present their work, experiences, observations, and opinions on the benefits and unmet challenges of cell-based therapies.

Read more...
Print
 

Course Director

Warren Sherman, MD

New York-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

Print
 

Course Co-Directors

Josef Bartunek, MD, PhD
Cardiovascular Center, OLV Hospital
Aalst, Belgium

Henricus J. Duckers, MD, PhD
Erasmus University Hospital
Rotterdam, The Netherlands

Amit Patel, MD, MS
University of Utah
Salt Lake City, UT

Marc S. Penn, MD, PhD
Summa Health System
Cleveland, OH

Print
 

Planning Commitee

Keith L. March, MD, PhD
Indianapolis Center for Vascular Biology and Medicine
Indianapolis, IN

Gordana Vunjak-Novakovic, PhD
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

Wojciech Wojakowski, MD, PhD
Third Division of Cardiology
Katowice, Poland

Print
 

Faculty

Rahul Aras, PhD

Jvuentas Therapeutics
Cleveland, OH

Jozef Bartunek, MD, PhD

Cardiovascular Center, OLV Hospital
Aalst, Belgium

P. Kevin Benoit, BA, MA, MPA

Plymouth, MA

Roberto Bolli, MD

Jewish Hospital Heart & Lung Institute
Louisville, KY

Kenneth M Borow, MD

Please Provide Info
Bryn Mawr, PA

Todd J. Brinton, MD

Stanford University Medical Center
Stanford, CA

Antonio Campos de Carvalho, MD

National Cardiology Institute
Rio de Janeiro, Brazil

Timothy Caulfield, LLM, FRSC

Canada Research Chair in Health Law & Policy
Alberta, Canada

Stefanie Dimmeler, PhD

University of Frankfurt
Frankfurt, Germany

Henricus J. Duckers, MD, PhD

Erasmus Medical Center
Rotterdam, The Netherlands

Stephen G. Ellis, MD

Cleveland Clinic Foundation
Cleveland, OH

Stephen E. Epstein, MD

Washington Hospital Center
Washington, DC

Matthew Feshbach

OKYANOS
AL

James Goodrich, MS

Aastrom Biosciences
Ann Arbor, MI

Roger J. Hajjar, MD

Mount Sinai Medical Center
New York, NY

Timothy D. Henry, MD

Minneapolis Heart Institute Foundation
Minneapolis, MN

Christian Homsy, MD, MBA

Cardio3 BioSciences S.A.
Mont-Saint-Guibert, Belgium

Andrea Hunt

Baxter Healthcare Corporation
Deerfield, IL

Thomas Ichim, PhD

Medistem Laboratories , Inc
San Diego, CA

David James

Invetech
Guilford, CT

Robert Kass, PhD

Columbia University Medical Center
New York, NY

Hyo-Soo Kim, MD, PhD

Seoul National University Hospital
Seoul, South Korea

Vijay Kumar, PhD

ThermoGenesis Corporation
Rancho Cordova, CA

Randall J. Lee, MD, PHD

University of California, San Francisco
San Francisco, CA

Robert Lindblad, MD

The EMMES Corporation
Rockville, MD

Raj Makkar, MD

Cedars-Sinai Medical Center
Los Angeles, CA

Linda Marban, PhD

Capricor, Inc
Los Angeles, CA

Keith L. March, MD, PhD

Indiana Center for Vascular Biology and Medicine
Indianapolis, IN

Maritza Mayorga, PhD

Northeast Ohio Medical University
Beachwood, OH

Les Miller, MD

Univeristy Southern Florida
Please Provide Info, FL

Alexander M Milstein, MD

Cytori
San Diego, CA

Thomas F. O'Donnell, MD

Tufts Medical Center
Boston, MA

Amit Patel, MD, MS

University of Utah
Salt Lake City, UT

Andrew Pecora, MD

Hackensack UMC
AL

Marc S. Penn, MD, PhD

Summa Cardiovascular Institute
Akron, OH

Emerson C. Perin, MD, PhD

Texas Heart Institute
Houston, TX

Kai Pinkernell, MD, MBA

Miltenyi Biotec GmbH
Bergisch Gladbach, Germany

Thomas J. Povsic, MD, PhD

Duke University Medical Center
Chapel Hill, NC

William Prather, MD

Pluristem Therapeutics
Edwards, CO

Robert A Preti, PhD

Progenitor Cell Therapy
Allendale, NJ

Arshed A. Quyyumi, MD

Atlanta, GA

Amish Raval, MD

UW Health
Madison, WI

Jay W. Schneider, MD

UT Southwestern Medical Center
Dallas, TX

Michael Schuster

Mesoblast
New York, NY

Warren Sherman, MD

NewYork-Presbyterian Hosptial
New York, NY

Christof Stamm, MD

German Heart Institute
Berlin, Germany

Gustav Steinhoff, MD, PhD

Klinik und Poliklinik fur Herzchirurgie Medizinische Fakultat
Rostock, Germany

Gregg W. Stone, MD

NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

Anthony Ting, PhD

Athersys, Inc.
Cleveland, OH

Jay H Traverse, MD

Minneapolis Heart Institute Foundation
Minneapolis, MN

Jorge Tuma, MD

CENCOR / Maison de Sante Clinic
Lima, Peru

Gordana Vunjak-Novakovic, PhD

Columbia University Medical Center
New York, NY

Christine Wallrapp, PhD

CellMed AG
Alzenau, Germany

Mark Weinreb

BioRestorative Therapies
Jupiter, FL

Wojciech Wojakowski, MD, PhD

Third Division of Cardiology
Katowice, Poland

Randy Yerden, B.S.

BioSpherix, Ltd.
Lacona, NY

Andreas M. Zeiher, MD

University Hospital Medical Center
Frankfurt, Germany

back to top

Print
 

Agenda

The complete 2012 agenda is now available online.

View the Agenda...
Print